IRX-101

· iRenix Medical, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IRX-101, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections [Phase 3]